Evidence map›Paper›PMID 35558360›Full record

ArticleIEEE network

Service Level Agreements for 5G-Enabled Healthcare Systems: Challenges and Considerations.

Haneya Naeem Qureshi, Marvin Manalastas, Ali Imran, Mohamad Omar Al Kalaa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IEEE network. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Haneya Naeem QureshiCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Marvin ManalastasSchool of Electrical and Computer Engineering, University of Oklahoma, Tulsa, OK, USA.
Ali ImranSchool of Electrical and Computer Engineering, University of Oklahoma, Tulsa, OK, USA.
Mohamad Omar Al KalaaCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

5G and Beyond 5G (B5G) communication networks, with their characteristics of increasing speed, connectivity, reliability, availability and capacity while reducing latency, have the potential to transform the healthcare sector by opening possibilities for novel healthcare use cases and applications. Service level agreements (SLAs) can help enable these new healthcare use cases by documenting the communication requirements, performance standards, and roles and responsibilities of the stakeholders involved in providing safe and effective 5G-enabled healthcare to patients. However, the peculiarities and nuances of 5G implementations give rise to gaps in this area that should be addressed to streamline the implementation of 5G technology in healthcare. This magazine article highlights the key challenges and describes open research questions related to SLAs for 5G-healthcare systems. Addressing the research challenges in this space will help in developing robust SLAs that can ensure that device manufacturers, network service providers, users, and regulatory authorities share a common framework to safely integrate 5G & B5G technology in healthcare.

Identifiers

PMID35558360
PMCPMC9087298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.